141 related articles for article (PubMed ID: 3127328)
21. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
[TBL] [Abstract][Full Text] [Related]
22. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
23. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.
Thornhill MH; Haskard DO
J Immunol; 1990 Aug; 145(3):865-72. PubMed ID: 1695647
[TBL] [Abstract][Full Text] [Related]
24. TNF in combination with interferon-gamma is cytotoxic to normal, untransformed mouse and rat embryo fibroblast-like cells.
Suffys P; Beyaert R; Van Roy F; Fiers W
Anticancer Res; 1989; 9(1):167-71. PubMed ID: 2495751
[TBL] [Abstract][Full Text] [Related]
25. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.
Mori K; Stone S; Braverman LE; DeVito WJ
Endocrinology; 1996 Nov; 137(11):4994-9. PubMed ID: 8895373
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory effect of tumor necrosis factor and interleukin-1 on Ia induction by interferon-gamma on endothelial cells from murine central nervous system microvessels.
Tanaka M; McCarron RM
J Neuroimmunol; 1990 May; 27(2-3):209-15. PubMed ID: 2110185
[TBL] [Abstract][Full Text] [Related]
27. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
Hoon DS; Banez M; Okun E; Morton DL; Irie RF
Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium.
Leszczynski D
Am J Pathol; 1990 Jan; 136(1):229-37. PubMed ID: 2105059
[TBL] [Abstract][Full Text] [Related]
29. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
Buscema M; Todd I; Deuss U; Hammond L; Mirakian R; Pujol-Borrell R; Bottazzo GF
J Clin Endocrinol Metab; 1989 Aug; 69(2):433-9. PubMed ID: 2502555
[TBL] [Abstract][Full Text] [Related]
30. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
[TBL] [Abstract][Full Text] [Related]
31. Hypomethylation enhances Ia antigen expression by the FRTL5 rat thyroid cell line.
Weetman AP
Cell Biol Int Rep; 1988 Oct; 12(10):919-24. PubMed ID: 2465093
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma induces HLA-DR expression by thyroid epithelium.
Todd I; Pujol-Borrell R; Hammond LJ; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1985 Aug; 61(2):265-73. PubMed ID: 3930110
[TBL] [Abstract][Full Text] [Related]
33. Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.
Antonelli A; Ferrari SM; Mancusi C; Mazzi V; Pupilli C; Centanni M; Ferri C; Ferrannini E; Fallahi P
Immunobiology; 2013 May; 218(5):690-5. PubMed ID: 22944249
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha alters bovine luteal cell synthetic capacity and viability.
Benyo DF; Pate JL
Endocrinology; 1992 Feb; 130(2):854-60. PubMed ID: 1733731
[TBL] [Abstract][Full Text] [Related]
35. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha.
Yeoman H; Anderton JG; Stanley MA
Immunology; 1989 Jan; 66(1):100-5. PubMed ID: 15493270
[TBL] [Abstract][Full Text] [Related]
36. Interferon-gamma and tumour necrosis factor induce expression of major histocompatibility complex antigen on rat retinal astrocytes.
el-Asrar AM; Maimone D; Morse PH; Lascola C; Reder AT
Br J Ophthalmol; 1991 Aug; 75(8):473-5. PubMed ID: 1908315
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
Quirk SM; Porter DA; Huber SC; Cowan RG
Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
[TBL] [Abstract][Full Text] [Related]
38. Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-alpha.
Pang XP; Yoshimura M; Hershman JM
Thyroid; 1993; 3(4):325-30. PubMed ID: 8118227
[TBL] [Abstract][Full Text] [Related]
39. 1,25-Dihydroxyvitamin D3 antagonizes interferon-gamma-induced expression of class II major histocompatibility antigens on thyroid follicular and testicular Leydig cells.
Tokuda N; Mano T; Levy RB
Endocrinology; 1990 Sep; 127(3):1419-27. PubMed ID: 2117528
[TBL] [Abstract][Full Text] [Related]
40. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells.
Leeuwenberg JF; Van Damme J; Meager T; Jeunhomme TM; Buurman WA
Eur J Immunol; 1988 Sep; 18(9):1469-72. PubMed ID: 3139431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
